MedTrace Logo

Facilitating Assessment of At-Risk Sailors Using Technology

NCT04159480 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 279

Last updated 2026-03-02

Study results available
· View outcomes & findings →

Summary

Randomized clinical trial with individuals being allocated to experimental (Cogito Companion) or Active Control arms. Those in the latter will receive information regarding widely available mobile self-help apps via a custom mobile app built in MyCAP. This same platform will be used to collect data regarding symptoms. Randomization will be stratified by gender, force (Surface, Aviation), and smartphone model (Android, I-Phone), as Cogito algorithms differ based on smartphone platforms. Participants will be willing Naval personnel being redeployed to CONUS. Data is also being collected (feasibility/acceptability) to inform future implementation..

Conditions

  • Psychological Distress

Interventions

DEVICE

Experimental - Cogito Companion

Cogito Companion

BEHAVIORAL

Active Control

Use of MyCAP

Sponsors & Collaborators

  • University of Colorado, Denver

    collaborator OTHER

  • Military Suicide Research Consortium

    collaborator OTHER

  • VA Eastern Colorado Health Care System

    lead FED

Principal Investigators

  • Lisa Brenner, Ph.D. · VA/University of Colorado

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-09
Primary Completion
2023-03-29
Completion
2023-03-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04159480 on ClinicalTrials.gov